Product references — Lycopene

Mackinnon, E., et al. 2010. Supplementation with the antioxidant lycopene significantly decreases oxidative stress parameters and the bone resorption marker N-telopeptide of type I collagen in postmenopausal women. Osteoporos. Int. [Epub ahead of print.] URL (abstract): http://www.ncbi.nlm.nih.gov/pubmed/20552330 (accessed 06.22.2010).

Sahni, S., et al. 2009. Inverse association of carotenoid intakes with 4–y change in bone mineral density in elderly men and women: The Framingham Osteoporosis Study. Am. J. Clin. Nutr., 89 (1), 416–424. URL http://www.ncbi.nlm.nih.gov/pubmed/19056581 (accessed 12.21.2008).

Sahni, S., et al. 2009. Protective effect of total carotenoid and lycopene intake on the risk of hip fracture: A 17-year follow-up from the Framingham Osteoporosis Study. J. Bone Miner. Res., 24 (6), 1086–1094. URL: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2683648/?tool=pubmed (accessed 07.12.2010).

Yang, Z., et al. 2008. Serum carotenoid concentrations in postmenopausal women from the United States with and without osteoporosis. Int. J. Vitam. Nutr. Res., 78 (3), 105–111. URL (abstract): http://www.ncbi.nlm.nih.gov/pubmed/19003732 (accessed 12.21.2008).

De Pablo, P., et al. 2007. Antioxidants and other novel cardiovascular risk factors in subjects with rheumatoid arthritis in a large population sample. Arthritis Rheum., 57 (6), 953–962. URL (abstract): http://www.ncbi.nlm.nih.gov/pubmed/17665477 (accessed 12.21.2008).

Rao, L., et al. 2007. Lycopene consumption decreases oxidative stress and bone resorption markers in postmenopausal women. Osteoporos. Int., 18 (1), 109–115. URL (abstract): http://www.ncbi.nlm.nih.gov/pubmed/16941193 (accessed 12.22.2008).

Hsiao, G., et al. 2005. Inhibitory effects of lycopene on in vitro platelet activation and in vivo prevention of thrombus formation. J. Lab. Clin. Med., 146 (4), 216–226. URL (abstract): http://www.ncbi.nlm.nih.gov/pubmed/16194683 (accessed 12.22.2008).

Pattison, D., et al. 2005. Dietary beta-cryptoxanthin and inflammatory polyarthritis: Results from a population-based prospective study. Am. J. Clin. Nutr., 82 (2), 451–455. URL: http://www.ajcn.org/cgi/content/full/82/2/451 (accessed 12.21.2008).

Kim, G., et al. 2004. Lycopene suppresses the lipopolysaccharide-induced phenotypic and functional maturation of murine dendritic cells through inhibition of mitogen-activated protein kinases and nuclear factor-kappaB. Immunology, 113 (2), 203–211. URL (abstract): http://www.ncbi.nlm.nih.gov/pubmed/15379981 (accessed 12.22.2008).

Kim, L., et al. 2003. Lycopene II — effect on osteoblasts: The carotenoid lycopene stimulates cell proliferation and alkaline phosphatase activity of SaOS-2 cells. J. Med. Food, 6 (2), 79–86. URL (abstract): http://www.ncbi.nlm.nih.gov/pubmed/12935317 (accessed 12.22.2008).

Rao, L., et al. 2003. Lycopene I — effect on osteoclasts: Lycopene inhibits basal and parathyroid hormone-stimulated osteoclast formation and mineral resorption mediated by reactive oxygen species in rat bone marrow cultures. J. Med. Food., 6 (2), 69–78. URL (abstract): http://www.ncbi.nlm.nih.gov/pubmed/12935316 (accessed 12.22.2008).

Wattanapenpaiboon, N., et al. 2003. Dietary carotenoid intake as a predictor of bone mineral density. Asia Pac. J. Clin. Nutr., 12 (4), 467–473. URL (abstract): http://www.ncbi.nlm.nih.gov/pubmed/14672872 (accessed 12.21.2008).

Rauscher, R., et al. 1998. In vitro antimutagenic and in vivo anticlastogenic effects of carotenoids and solvent extracts from fruits and vegetables rich in carotenoids. Mutat. Res., 413 (2), 129–142. URL (abstract): http://www.ncbi.nlm.nih.gov/pubmed/9639691 (accessed 12.22.2008).